InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by DENKHAUS DONALD A, Director. Officer active across 1 company, notably Catalyst Pharmaceuticals, INC.. Aggregated, 6 disclosures have been recorded. History available since 5 January 2022. The latest transaction was disclosed on 10 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
40,000 shares@ US$2.530.0023% mcap37.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000045
40,000 shares@ US$2.530.0023% mcap18.8% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000045:0
50,000 shares@ US$3.350.0039% mcap31.2% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000031:0
50,000 shares@ US$3.350.0039% mcap62.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000031
1,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-21-000553
1,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-21-000553:0
6 of 6 declarations
About DENKHAUS DONALD A
Donald A. Denkhaus is a Board Member at Catalyst Pharmaceuticals, Inc. He plays a key role in the governance of the company, participating in strategic decisions and ensuring compliance with regulations. His expertise in the pharmaceutical sector is an asset to the board.
